May 22, 2023 — New research finds that the brains of otherwise healthy military personnel who are exposed to explosions ...
PET Imaging
Positron emission tomography (PET) is a nuclear imaging technology (also referred to as molecular imaging) that enables visualization of metabolic processes in the body. The basics of PET imaging is that the technique detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (also called radiopharmaceuticals, radionuclides or radiotracer). The tracer is injected into a vein on a biologically active molecule, usually a sugar that is used for cellular energy. PET systems have sensitive detector panels to capture gamma ray emissions from inside the body and use software to plot to triangulate the source of the emissions, creating 3-D computed tomography images of the tracer concentrations within the body.
May 12, 2023 — A newly published meta-analysis indicates that amino acid PET can accurately differentiate recurrent or ...
May 2, 2023 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of ...
Digital technology is opening remarkable opportunities for clinical positron emission tomography (PET) about which ...
May 2, 2023 — Metabolic disorders are involved in many common health conditions such as Alzheimer's, depression ...
April 28, 2023 — GE HealthCare to deliver two Cyclotrons next year, expanding South Africa’s capacity to produce ...
April 3, 2023 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...
Precision can have an enormous impact on patients. From diagnosis to patient monitoring (see “How Digital PET/CT Can ...
March 29, 2023 — A newly published literature review sheds light on how nuclear medicine brain imaging can help evaluate ...
March 29, 2023 — Ratio Therapeutics Inc., a pharmaceutical company that employs a suite of innovative technologies to ...
March 29, 2023 — In a partnership which aims to provide faster and safer medical imaging across Australia and New ...
PET is getting ready to venture outside oncology, cardiology and mainstream neurology. High on the list of new clinical ...
March 23, 2023 — Nuclidium announced that the Neuroendocrine Tumors Research Foundation (NETRF) has selected the company ...
March 21, 2023 — Positron Corporation, a molecular imaging device company that offers PET imaging systems and clinical ...
March 10, 2023 — Researchers found evidence of heart muscle inflammation in a small number of patients with acute ...
Analog is approximate. Digital is specific. Therein lies the fundamental difference between digital PET and its analog ...
February 23, 2023 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the European Association of ...
February 16, 2023 — TAE Life Sciences (TLS), a biological-targeted radiation therapy company developing next-generation ...
February 9, 2023 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...
February 2, 2023 — Five additional imaging centers across Allegheny Health Network (AHN) have been recognized by the ...
January 31, 2023 — Electronic cigarette (e-cigarette) users have greater lung inflammation than cigarette smokers and ...
December 14, 2022 — CytoSite Bio, a company developing precision imaging products that determine patient response to ...
December 2, 2022 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...
December 1, 2022 — A new method for determining whether patients with heart disease need coronary stents or bypass ...